Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in J Cell Physiol

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    July 2018
  1. BONONI I, Mazzoni E, Pietrobon S, Torreggiani E, et al
    High prevalence of serum IgG antibodies reacting to specific mimotopes of BK polyomavirus, a human oncogenic polyomavirus, in patients affected by uveal melanoma.
    J Cell Physiol. 2018 Jul 3. doi: 10.1002/jcp.26771.
    PubMed     Text format     Abstract available


    December 2017
  2. ROSS CL, Kaushik S, Valdes-Rodriguez R, Anvekar R, et al
    MicroRNAs in Cutaneous Melanoma: Role as Diagnostic and Prognostic Biomarkers.
    J Cell Physiol. 2017 Dec 11. doi: 10.1002/jcp.26395.
    PubMed     Text format     Abstract available


  3. JIANG X, Guan S, Qiao Y, Li X, et al
    Effects of poly(I:C) and MF59 co-adjuvants on immunogenicity and efficacy of survivin polypeptide immunogen against melanoma.
    J Cell Physiol. 2017 Dec 5. doi: 10.1002/jcp.26317.
    PubMed     Text format     Abstract available


    January 2017
  4. BRINCKERHOFF CE
    Cancer Stem Cells (CSCs) in Melanoma: There's Smoke, But Is There Fire?
    J Cell Physiol. 2017 Jan 11. doi: 10.1002/jcp.25796.
    PubMed     Text format     Abstract available


  5. CANTILE M, Scognamiglio G, Marra L, Aquino G, et al
    HOTAIR Role in Melanoma Progression and its Identification in the Blood of Patients with Advanced Disease.
    J Cell Physiol. 2017 Jan 9. doi: 10.1002/jcp.25789.
    PubMed     Text format     Abstract available


    November 2016
  6. HELAL-NETO E, Brandao-Costa RM, Saldanha-Gama R, Ribeiro-Pereira C, et al
    Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of alphavbeta3/VEGFR2 Axis.
    J Cell Physiol. 2016;231:2464-73.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: